496 related articles for article (PubMed ID: 17582145)
1. Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy.
Hehenkamp WJ; Volkers NA; Broekmans FJ; de Jong FH; Themmen AP; Birnie E; Reekers JA; Ankum WM
Hum Reprod; 2007 Jul; 22(7):1996-2005. PubMed ID: 17582145
[TBL] [Abstract][Full Text] [Related]
2. Uterine artery embolization as a treatment option for uterine myomas.
Marshburn PB; Matthews ML; Hurst BS
Obstet Gynecol Clin North Am; 2006 Mar; 33(1):125-44. PubMed ID: 16504811
[TBL] [Abstract][Full Text] [Related]
3. A prospective comparison of the impact of uterine artery embolization, myomectomy, and hysterectomy on ovarian function.
Hovsepian DM; Ratts VS; Rodriguez M; Huang JS; Aubuchon MG; Pilgram TK
J Vasc Interv Radiol; 2006 Jul; 17(7):1111-5. PubMed ID: 16868163
[TBL] [Abstract][Full Text] [Related]
4. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): peri- and postprocedural results from a randomized controlled trial.
Hehenkamp WJ; Volkers NA; Donderwinkel PF; de Blok S; Birnie E; Ankum WM; Reekers JA
Am J Obstet Gynecol; 2005 Nov; 193(5):1618-29. PubMed ID: 16260201
[TBL] [Abstract][Full Text] [Related]
5. [Impact of uterine fibroid embolization with danazol alginate microsphere on ovarian function and subsequent pregnancy].
Lei CZ; Xiang Y; Ao GK; Li L; Shi YC; Bao YR; Xu CJ; Hong H; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2007 Oct; 42(10):701-4. PubMed ID: 18241548
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial.
Volkers NA; Hehenkamp WJ; Smit P; Ankum WM; Reekers JA; Birnie E
J Vasc Interv Radiol; 2008 Jul; 19(7):1007-16; quiz 1017. PubMed ID: 18589314
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the influence of three fibroid treatment options: supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve - an observational study.
Czuczwar P; Stepniak A; Milart P; Paszkowski T; Wozniak S
J Ovarian Res; 2018 Jun; 11(1):45. PubMed ID: 29859107
[TBL] [Abstract][Full Text] [Related]
8. Fresh human orthotopic ovarian cortex transplantation: long-term results.
Sánchez M; Alamá P; Gadea B; Soares SR; Simón C; Pellicer A
Hum Reprod; 2007 Mar; 22(3):786-91. PubMed ID: 17110398
[TBL] [Abstract][Full Text] [Related]
9. Anti-Mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause.
La Marca A; De Leo V; Giulini S; Orvieto R; Malmusi S; Giannella L; Volpe A
J Soc Gynecol Investig; 2005 Oct; 12(7):545-8. PubMed ID: 16046154
[TBL] [Abstract][Full Text] [Related]
10. Anti-mullerian hormone as a marker of ovarian reserve.
Tremellen KP; Kolo M; Gilmore A; Lekamge DN
Aust N Z J Obstet Gynaecol; 2005 Feb; 45(1):20-4. PubMed ID: 15730360
[TBL] [Abstract][Full Text] [Related]
11. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial.
Volkers NA; Hehenkamp WJ; Birnie E; Ankum WM; Reekers JA
Am J Obstet Gynecol; 2007 Jun; 196(6):519.e1-11. PubMed ID: 17547877
[TBL] [Abstract][Full Text] [Related]
12. The impact of uterine artery embolization on ovarian reserve: A systematic review and meta-analysis.
El Shamy T; Amer SAK; Mohamed AA; James C; Jayaprakasan K
Acta Obstet Gynecol Scand; 2020 Jan; 99(1):16-23. PubMed ID: 31370100
[TBL] [Abstract][Full Text] [Related]
13. Comparing the effect of laparoscopic supracervical and total hysterectomy for uterine fibroids on ovarian reserve by assessing serum anti-mullerian hormone levels: a prospective cohort study.
Yuan H; Wang C; Wang D; Wang Y
J Minim Invasive Gynecol; 2015; 22(4):637-41. PubMed ID: 25653041
[TBL] [Abstract][Full Text] [Related]
14. Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial.
Hehenkamp WJ; Volkers NA; Birnie E; Reekers JA; Ankum WM
Cardiovasc Intervent Radiol; 2006; 29(2):179-87. PubMed ID: 16447002
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous uterine artery embolization for the treatment of symptomatic fibroids: current status.
Lupattelli T; Basile A; Garaci FG; Simonetti G
Eur J Radiol; 2005 Apr; 54(1):136-47. PubMed ID: 15797303
[TBL] [Abstract][Full Text] [Related]
16. Mid-term clinical results and patient satisfaction after uterine artery embolization in women with symptomatic uterine fibroids.
Smeets AJ; Lohle PN; Vervest HA; Boekkooi PF; Lampmann LE
Cardiovasc Intervent Radiol; 2006; 29(2):188-91. PubMed ID: 16195836
[TBL] [Abstract][Full Text] [Related]
17. Anti-Müllerian hormone: a new marker for ovarian function.
Visser JA; de Jong FH; Laven JS; Themmen AP
Reproduction; 2006 Jan; 131(1):1-9. PubMed ID: 16388003
[TBL] [Abstract][Full Text] [Related]
18. Uterine artery embolization for symptomatic adenomyosis with or without uterine leiomyomas with the use of calibrated tris-acryl gelatin microspheres: midterm clinical and MR imaging follow-up.
Lohle PN; De Vries J; Klazen CA; Boekkooi PF; Vervest HA; Smeets AJ; Lampmann LE; Kroencke TJ
J Vasc Interv Radiol; 2007 Jul; 18(7):835-41. PubMed ID: 17609441
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of uterine fibromyoma with bilateral uterine artery embolization: state of the art].
Lupattelli T; Clerissi J; Basile A; Minnella DP; Donati Sarti R; Gerli S; Di Renzo G
Minerva Ginecol; 2007 Aug; 59(4):427-39. PubMed ID: 17923833
[TBL] [Abstract][Full Text] [Related]
20. Ovarian reserve following uterine artery embolization in women of reproductive age: a preliminary report.
McLucas B; Danzer H; Wambach C; Lee C
Minim Invasive Ther Allied Technol; 2013 Feb; 22(1):45-9. PubMed ID: 23311507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
